Cuog Phase Ii Randomized Study of Custirsen (ogx-011) Combination Therapy in Patients With Castrate Resistant Prostate Cancer (crpc) Who Relapsed on or Within Six Months of 1st-line Docetaxel Therapy
Year: 2009
Type: article
Source: The Journal of Urology
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2127006229
